ORLANDO, Florida, July 6, 2020 – Aspire Health Science, LLC (the “Company” or “Aspire”), an FDA registered cGMP manufacturing facility specialized in the research, development, and manufacturing of cell-based therapies. Through a licencing agreement with Hemostemix Inc. (“Hemostemix”), Aspire is responsible for manufacturing and managing clinical trial activities including patient data collections and processing of […]
Uncategorized
Aspire Health Science Announces US FDA Approval of IND Application Regarding Testing Proprietary ACT-20 Cellular Therapy Against COVID-19 Pneumonia
ORLANDO, Florida, June 1, 2020 – Aspire Health Science, LLC (the “Company” or “Aspire”), an FDA registered cGMP manufacturing facility specialized in the research, development, and manufacturing of cell-based therapies, is thrilled to announce that it has received IND approval from the U.S. FDA to test the Company’s proprietary cellular therapy, ACT-20, against moderate to […]
